Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RNA Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00455585
What this trial is testing

Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products

Who this might be right for
HIV Infections
Makerere University 18
Not applicableStudy completedNCT03916484
What this trial is testing

AllyQuest Adherence App Intervention for HIV-positive Men Who Have Sex With Men and Transgender Women: Pilot Trial

Who this might be right for
HivHIV/AIDSMedication Adherence+2 more
University of North Carolina, Chapel Hill 71
Post-approval studies (Phase 4)Study completedNCT00002343
What this trial is testing

Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Pharmacia 200
Large-scale testing (Phase 3)Study completedNCT00483054
What this trial is testing

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 142
Testing effectiveness (Phase 2)Study completedNCT00001122
What this trial is testing

An Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 74
Post-approval studies (Phase 4)Study completedNCT01059422
What this trial is testing

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Who this might be right for
HIV InfectionsTuberculosis
Central Institute of Epidemiology, Moscow, Russia 10
Large-scale testing (Phase 3)Study completedNCT00662870
What this trial is testing

Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

Who this might be right for
DiphtheriaTetanusWhooping Cough+2 more
Sanofi 1,941
Large-scale testing (Phase 3)Study completedNCT00404651
What this trial is testing

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 1,189
Early research (Phase 1)Study completedNCT05362955
What this trial is testing

5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa

Who this might be right for
CIN 2/3HIV Infections
UNC Lineberger Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00000825
What this trial is testing

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Not applicableUnknownNCT05071573
What this trial is testing

Optimised Electronic Patient Records to Improve Clinical Monitoring of HIV-positive Patients in Rural South Africa

Who this might be right for
HIV Infections
University of Sussex 1,500
Very early researchUnknownNCT05832073
What this trial is testing

Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1

Who this might be right for
Rabies Virus Infection
Changchun BCHT Biotechnology Co. 152
Early research (Phase 1)Study completedNCT00000878
What this trial is testing

Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 26
Testing effectiveness (Phase 2)Study completedNCT00004584
What this trial is testing

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT00463437
What this trial is testing

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

Who this might be right for
Hepatitis BAcellular PertussisTetanus+3 more
GlaxoSmithKline 1,437
Not applicableUnknownNCT04878601
What this trial is testing

Innovative Strategies to Increase ART Initiation and Viral Suppression Among HIV-positive Men in Malawi

Who this might be right for
Hiv
University of California, Los Angeles 470
Testing effectiveness (Phase 2)Study completedNCT00002192
What this trial is testing

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Anderson Clinical Research
Testing effectiveness (Phase 2)Study completedNCT01296113
What this trial is testing

Chemotherapy for Lung Cancer in HIV-positive Patients

Who this might be right for
Non-small Cell Lung CancerHiv-positive
Intergroupe Francophone de Cancerologie Thoracique 61
Large-scale testing (Phase 3)Study completedNCT00052195
What this trial is testing

Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People

Who this might be right for
TuberculosisHIV Infections
Dartmouth-Hitchcock Medical Center 1,975
Not applicableStudy completedNCT00000914
What this trial is testing

The Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 800
Next Page